Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Paragon Care Limited ( (AU:PGC) ) has issued an update.
Paragon Care Limited has announced the appointment of Carmen Riley as the new Chief Executive Officer, effective July 1, 2025. This transition follows the successful merger of Oborne, ParagonCare, and Clifford Hallam Healthcare Pty Ltd (CH2), and aligns with the company’s long-term growth strategy. Carmen Riley, who has been with CH2 for 15 years and served as Chief Operating Officer, will take over from David Collins, who will remain as Managing Director until June 2026. This leadership change is expected to bolster Paragon Care’s growth prospects and enhance shareholder equity, with David Collins focusing on mergers and acquisitions during the transition period.
The most recent analyst rating on (AU:PGC) stock is a Buy with a A$0.52 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, supplying durable medical equipment, medical devices, consumable medical products, and maintenance services to the health, aged care, and veterinary markets across Australia, New Zealand, and Asia. It also distributes pharmaceuticals, medical consumables, and complementary medicines within the Australian healthcare market.
Average Trading Volume: 562,594
Technical Sentiment Signal: Buy
Current Market Cap: A$678.7M
Find detailed analytics on PGC stock on TipRanks’ Stock Analysis page.